Persistent Underperformance Against Benchmarks
Trigyn Technologies has been under considerable pressure over multiple time horizons when compared to the broader market benchmark, the Sensex. Over the past week, the stock has declined by 9.95%, markedly underperforming the Sensex’s modest 1.27% fall. This underperformance extends over longer periods, with the stock down 18.82% in the last month versus the Sensex’s 9.48% decline. Year-to-date figures reveal a stark contrast, as Trigyn Technologies has lost 36.62% of its value, nearly triple the Sensex’s 13.66% fall. The one-year and three-year returns further highlight the stock’s struggles, with losses of 39.65% and 51.61% respectively, while the Sensex has posted gains of 5.18% and 27.63% over the same periods. Even over five...
Read full news article













